There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real...
The new challenge is the usage of in silico methods in the field of
nanotechnology. Nanotechnology is an innovative science that involves
the designing, characterization, production...
Introduction - the problem:Treatment of oncological patients with targeted therapy has been carried out in our country for over 15 years. However, compared to...
